18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma

Cancer

Volumn 115, Issue 11, 2009, Pages 2531-2538

  Shibata, Hidekatsu ^a,b   Nomori, Hiroaki ^a,c   Uno, Kimiichi ^d   Sakaguchi, Kazuya ^d   Nakashima, Rumi ^e   Iyama, Kenichi ^a   Tomiyoshi, Katsumi ^a   Kaji, Masahiro ^f   Goya, Tomoyuki ^b   Suzuki, Takashi ^g   Horio, Hirotoshi ^h  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d Nishidai Clinic   (Japan)

^e JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^f SAISEIKAI CENTRAL HOSPITAL   (Japan)

^g SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^h TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Acetate; Fluorodeoxyglucose; Histologic type; Positron emission tomography; Thymoma

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18; CARBON; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; THYMOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; THYMOMA; THYMUS NEOPLASMS;

EID: 66649113098     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24278     Document Type: Article

References (20)

1. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose positron emission tomography. Clin Cancer Res. 2000;124:278-284.
2. Nomori H, Watanabe K, Ohtsuka T, et al. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1N0M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396-401. (Pubitemid 39194695)
3. Watanabe K, Nomori H, Ohtsuka T, et al. F-18 fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinoma. Jpn J Clin Oncol. 2006;36:403-409. (Pubitemid 44304797)
4. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC.Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart.Lyon, France: IARC Press; 2004.
5. Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med. 2006;47:1628-1634. (Pubitemid 47545028)
6. Sasaki M, Kuwabara Y, Ichiya Y, et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med. 1999;40:1595-1601. (Pubitemid 29471147)
7. El-Bawab H, Al-Sugair AA, Rafay M, Hajjar W, Mahdy M, Al-Kattan K. Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg. 2007;31:731-736. (Pubitemid 46400514)
8. Howard BV. Acetate as a carbon source for lipid synthesis in cultured cells. Biochim Biophys Acta. 1977;488:145-151. (Pubitemid 8143471)
9. 11C-acetate into the lipids of isolated epidermal cells. Br J Dermatol. 1976;94:243-252.
10. Brown M, Marshall DR. Sobel BE, et al. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation. 1987;76:687-696. (Pubitemid 17136145)
11. Lear JL. Relationship between myocardial clearance rates of carbon-11-acetate-deribed radiolabel and oxidative metabolism: physiologic basis and clinical significance. J Nucl Med. 1991;32:1957-1960.
12. Ho C, Yeung DW. C-11 acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213-221.
13. 11C-acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
14. Nomori H, Kosaka N, Watanabe K, et al. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Ann Thorac Surg. 2005;80:2020-2025. (Pubitemid 41718021)
15. Ohtsuka T, Nomori H, Watanabe K, et al. Positive imaging of thymoma by 11C-acetate positron emission tomography. Ann Thorac Surg. 2006;81:1132-1134. (Pubitemid 43247714)
16. Kuo TT, Chan JK. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol. 1998;22:1474-1481. (Pubitemid 28550642)
17. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinomas. A clinicopathologic study of 22 cases. Am J Surg Pathol. 1996;20:1469-1480. (Pubitemid 26411715)
18. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994;44:359-367. (Pubitemid 24153752)
19. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117-122. (Pubitemid 32276075)
20. Morimoto K, Kanoh K. The role of the de novo synthetic pathway in forming molecular species of phospholipids in resting lymphocytes from human tonsils. Biochim Biophys Acta. 1980;617:51-64. (Pubitemid 10185882)